ReviewCardiovascular diabetology2019
Class effects of SGLT2 inhibitors on cardiorenal outcomes.
Aaron Y Kluger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
76 papers cite itlatest 60 shown
this paperpooled ittrialcites it
ReviewCardiovascular diabetology2019
Aaron Y Kluger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.